California State Teachers Retirement System (CalSTRS)’s Aligos Therapeutics ALGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,240
Closed -$67K 3132
2022
Q1
$67K Sell
1,240
-70
-5% -$5.61K ﹤0.01% 2957
2021
Q4
$389K Buy
1,310
+25
+2% +$9.12K ﹤0.01% 2602
2021
Q3
$498K Buy
1,285
+249
+24% +$98.5K ﹤0.01% 2458
2021
Q2
$528K Buy
1,036
+394
+61% +$251K ﹤0.01% 2609
2021
Q1
$365K Buy
642
+31
+5% +$20.6K ﹤0.01% 2655
2020
Q4
$422K Buy
+611
New +$298K ﹤0.01% 2492

Other funds holding ALGS

California State Teachers Retirement System (CalSTRS)'s ALGS Position: Q2 2022 in Review

California State Teachers Retirement System (CalSTRS) sold out of Aligos Therapeutics (ALGS) in Q2 2022, closing a stake of 1,240 shares — an estimated $67K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in ALGS in Q4 2020 and held it in 6 quarters. The position peaked at $528K in Q2 2021. 59 funds tracked by Wall St. Rank hold ALGS as of Q2 2022.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Aligos Therapeutics position as of Q2 2022 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 1,240 Aligos Therapeutics shares in Q2 2022, an estimated $67K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Aligos Therapeutics in Q4 2020 and held it in 6 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Aligos Therapeutics position peaked at $528K in Q2 2021.
  • 59 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q2 2022.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2022, filed 15 Aug 2022.